Actavis Generics is a global pharmaceutical company focused on developing,
manufacturing ... In 1993, Actavis, then Watson, announced its initial public
offering (IPO) of shares of common stock. ......
Oct 31, 2012 ... Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company
focused on developing, manufacturing and distributing generic, ...
Watson Pharmaceuticals, Inc. (NYSE-WPI) is a global specialty pharmaceutical
company with approximately $3 billion in revenues, a broad product line and ...
Jan 25, 2013 ... Watson Pharmaceuticals is no more. The generic drug company has officially
taken the name of its most recent acquisition target, Actavis ...
Stock analysis for Allergan plc (WPI) including stock price, stock chart, company
news, key statistics, fundamentals and company profile.
Jun 17, 2013 ... Watson Pharmaceuticals, Inc., a corporation; Par Pharmaceutical Companies, Inc
., a corporation; Paddock Laboratories, Inc., a corporation; ...
Oct 15, 2012 ... The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and
Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz ...
Watson Pharmaceuticals, Inc. is a global leader in the development and
distribution of pharmaceuticals with a broad portfolio of generic products and a ...
77 Watson Pharmaceuticals reviews. A free inside look at company reviews ...
2008–2016, Glassdoor. Glassdoor ® is a registered trademark of Glassdoor, Inc.
Dec 14, 2012 ... The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights
and assets to 18 drugs to Sandoz International GmbH and Par ...